project - EIP-AGRI Operational Group
OBTAINMENT OF ADDED-VALUE PRODUCTS FROM SLAUGHTERHOUSE WASTE BLOOD AS A LOW-COST AND SUSTAINABLE MANAGEMENT ALTERNATIVE
OBTENCIÓN DE PRODUCTOS DE ALTO VALOR AÑADIDO A PARTIR DE SANGRE RESIDUAL DE MATADERO COMO ALTERNATIVA DE GESTIÓN SOSTENIBLE Y DE BAJO COSTE
Kontext
It is estimated that slaughterhouses in Spain generate 5.1 M tonnes of by-products per year, of which 200 M kg is blood. This by-product is of particular concern from an environmental point of view, given the high volumes generated, its pollutant load and complex composition, which make it difficult to manage. Nowadays, despite its high potential for obtaining high added value products, it is mostly managed as SANDACH waste. Although this involves a significant administrative and legal burden and an associated cost, it is the only economically viable alternative for most companies. On the one hand, having an on-site protein recovery system, taking into account the alternatives currently available, involves a minimum estimated cost of around €5m, which implies a very high price that the vast majority of companies in the sector cannot afford. An alternative could be centralised treatment systems, however, they also involve a significant investment at industrial level, in terms of the environmental impact of the activity (on-site activity does not generate new environmental impacts), which limits their development. In addition, they also have a significant environmental impact due to the carbon footprint of waste transport. Currently, only large slaughterhouses located in Catalonia and in the Mediterranean Arc manage blood in this way, which represents around a 30 % of the total. The meat sector needs to focus on exploiting the opportunities presented by slaughterhouse blood and rely on science and technology to develop low-cost management alternatives that can be adopted by companies and move it from being an undesirable waste to a valuable resource.
Activities
Production of protein hydrolysates; obtaining biostimulants with high added value; obtaining protein-rich food ingredients; validation of biostimulants based on the use of bovine blood hydrolysate in agri-food crops; validation of functional foods based on the use of porcine blood protein hydrolysates; validation of meat products based on the use of porcine blood protein hydrolysate; comparison of biostimulants formulated with bovine or porcine blood protein hydrolysates; determination of techno-economic feasibility, environmental sustainability, and social acceptability.
Activities
Elaboración de hidrolizados proteicos; obtención de bioestimulantes de alto valor añadido; obtención de ingredientes alimentarios ricos en proteínas; validación de bioestimulantes basados en la utilización de hidrolizado de sangre vacuna en cultivos agroalimentarios; validación de alimentos funcionales basados en la utilización de hidrolizados proteicos de sangre porcina; validación de productos cárnicos basados en la utilización de hidrolizado proteico de sangre porcina; comparativa de bioestimulantes formulados con hidrolizados proteicos de sangre vacuna o porcina; determinación de la viabilidad tecnoeconómica, sostenibilidad ambiental, y aceptación social.
Project details
- Main funding source
- CAP Strategic Plans 2023-2027 for Operational Groups
- Additional funding source
- No additional funding source
- Project contribution to EU Strategies
-
- Reducing nutrient losses and the use of fertilisers, while maintaining soil fertility
- Protecting and/or restoring of biodiversity and ecosystem services within agrarian and forest systems
- Territorial scope
- Cross-border
Budget information
-
EAFRD contribution EUR 109 636.12
-
National co-financing EUR 27 409.03
-
EAFRD contribution EUR 107 939.66
-
National co-financing EUR 26 984.91
-
EAFRD contribution EUR 75 957.78
-
National co-financing EUR 18 989.45
-
EAFRD contribution EUR 107 980.32
-
National co-financing EUR 26 995.08
-
EAFRD contribution EUR 63 988.02
-
National co-financing EUR 15 997.00
-
EAFRD contribution EUR 14 465.96
-
National co-financing EUR 3 616.49
2 Practice Abstracts
A)Valorización de sangre bovina/porcina para la obtención de bioestimulantes para fertilización. Indicadores: (1) 500 L a partir de sangre bovina; (2) 1L a partir de sangre porcina; (3) validación a TRL 6-7 de los de sangre bovina en al menos 3 cultivos; (4) comparación (laboratorio) entre bioestimulantes de sangre bovina y porcina considerando productividad de los cultivos y coste/beneficio.
B)Ingredientes funcionales con alto contenido proteico a partir de sangre porcina para ser utilizados en la formulación de complementos alimenticios o en productos cárnicos. Indicadores: (1) 4 kg de ingredientes funcionales procedentes de sangre de cerdo para uso en complementos alimenticios; (2) 1 kg de ingredientes funcionales procedentes de sangre de cerdo; (3) validación a TRL 6-7 de los ingredientes proteicos para ser utilizados en la fabricación de al menos 1 tipo de complemento. Validación a TRL 5-6 del uso de ingredientes funcionales directamente en productos cárnicos dentro de la industria cárnica. C)Información sobre la viabilidad técnico-económica, sostenibilidad ambiental y aceptabilidad social de los productos obtenidos. Indicador: (1) 3 informes.
A)Valorisation of bovine and porcine blood to obtain biostimulants for fertilisation. Indicators: (1) 500 L of biostimulants from cattle blood; (2) 1L of biostimulants from pig blood; (3) validation at TRL 6-7 of the biostimulants from cattle blood in at least 3 types of crops; (4) comparison at laboratory scale between biostimulants derived from bovine and porcine blood considering at least crop productivity and cost/benefit.
B)Functional ingredients with high protein content from pig blood to be used in the formulation of food supplements or directly in meat products. Indicators: (1) 4 kg of functional ingredients from pig blood to be used in food supplements; (2) 1 kg of functional ingredients from pig blood; (3) validation to TRL 6-7 of the protein ingredients to be used in the manufacture of at least 1 type of food supplement. Validation to TRL 5-6 of the use of functional ingredients directly in meat products in the framework of a circular economy model within the meat industry itself.
C)Information on the technical-economic feasibility, environmental sustainability and social acceptability of the products obtained. Indicator: (1) 3 report .
The main objective is to offer a technically viable and sustainable alternative for the management of blood generated in slaughterhouses by obtaining added value products. Specific objectives: (1) to recover waste bovine/porcine blood origin as a biostimulant and validate its use in agriculture; (2) to recover waste porcine blood as an ingredient with high protein content and validate its use in tfunctional foods and meat products for human consumption; and (3) to determine the viability and degree of social acceptance of the biostimulants and functional ingredients.
El principal objetivo es ofrecer una alternativa técnicamente viable y sostenible para la gestión de la sangre generada en los mataderos mediante la obtención de productos de valor añadido. Objetivos específicos: (1) valorizar residuos de sangre de origen bovino/porcino como bioestimulante y validar su uso en agricultura; (2) recuperar sangre porcina residual como ingrediente con alto contenido proteico y validar su uso en alimentos funcionales y productos cárnicos para consumo humano; y (3) determinar la viabilidad y el grado de aceptación social de los bioestimulantes e ingredientes funcionales.
Contacts
Project coordinator
-
Project coordinator
Project partners
-
Project partner
-
Project partner
-
Project partner
-
Project partner
-
Project partner